Cornerstone Advisors (Washington)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-847	Closed	-$10K	–	946
2017 Q2	$10K	Hold	847	–	–	0.01%	584
2017 Q1	$13K	Hold	847	–	–	0.01%	560
2016 Q4	$14K	Hold	847	–	–	0.01%	557
2016 Q3	$15K	Hold	847	–	–	0.01%	551
2016 Q2	$14K	Hold	847	–	–	0.01%	364
2016 Q1	$14K	Hold	847	–	–	0.01%	359
2015 Q4	$18K	Hold	847	–	–	0.02%	335
2015 Q3	$17K	Buy	+847	New	+$26.8K	0.02%	359

Other funds holding HZNP

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM